DIPIKA PATEL: Open Payments
NPI 1508873266 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,169 in 196 payments from 21 companies in 2025. Trend: 2023 $1,779 · 2024 $2,974 · 2025 $3,169
Food & beverage: $3,092Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 56 | $972 |
| Ardelyx, Inc. | 24 | $424 |
| Janssen Biotech, Inc. | 37 | $388 |
| Lilly USA, LLC | 12 | $219 |
| Ipsen Biopharmaceuticals, Inc | 7 | $184 |
| Gilead Sciences, Inc. | 9 | $172 |
| Aimmune Therapeutics, Inc. | 18 | $152 |
| Madrigal Pharmaceuticals | 9 | $151 |
| Phathom Pharmaceuticals, Inc. | 5 | $143 |
| QOL Medical, LLC | 2 | $55 |
Products named: IBSRELA, TREMFYA, RINVOQ, OMVOH, LINZESS, SKYRIZI, IQIRVO, REZDIFFRA.
Industry payments across SC — which companies pay providers there.
